Should I Buy JCAP? JCAP 2026 Analysis

Should You Buy Jefferson Capital Inc (JCAP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

21.960

1 Day change

4.47%

52 Week Range

23.800

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: Price is sitting right on key support (pre-market 20.925 vs S1 20.862), creating a favorable “buy-the-dip” entry for an impatient investor.
Upside skew is supported by strong YoY growth (Q3 2025) and a consistently bullish analyst stance with raised price targets ($26–$28) vs current ~21.
Near-term expectation: a choppy-to-weak tape is possible, but the risk/reward is attractive from support with clear technical levels (first upside targets Pivot 21.763, then R1 22.665).
Politicians/congress: No recent congress trading data available.
Trading flows: Hedge funds neutral; insiders neutral (no strong positioning signal either way).

Technical Analysis

Trend/Momentum: MACD histogram -0.169 (below zero) and only negatively contracting → downside momentum is still present but may be stabilizing.
RSI (6): 38.13 → weak/soft momentum, not oversold-extreme; consistent with a pullback that can still base before reversing.
Moving averages: Converging MAs → transition phase; confirms the stock is not in a clean uptrend right now.
Key levels:
- Support: S1 20.862, then S2 20.305
- Resistance/targets: Pivot 21.763, R1 22.665, R2 23.222
Pattern-based forward look (similar candlesticks): about -2.3% next week, +1.31% next month → aligns with a near-term dip/basing followed by potential recovery.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Analyst conviction remains strong: multiple Outperform ratings maintained with higher price targets.
- Credit cycle normalization thesis: Keefe Bruyette notes benefit from a continued normalization in U.S./international credit cycle and constructive industry fundamentals.
- Operational/industry positives cited by analysts: strong deployment capacity (low leverage), stable yields, increasing supply of distressed paper, and competitive barriers.
- Earnings catalyst ahead: QDEC 2025 earnings on 2026-03-02 (After Hours); Street EPS est. 0.71.

Neutral/Negative Catalysts

- Technical posture is still soft (MACD below zero; RSI weak), so upside may require basing first.
- No fresh news catalysts in the past week, reducing the chance of an immediate sentiment-driven pop.
- Broader market tone: pre-market S&P 500 -0.59% may weigh on risk appetite.
- Near-term statistical bias from pattern analysis points to mild weakness over the next week.

Financial Performance

Latest reported quarter: 2025/Q3
Revenue: $103.233M, +33.45% YoY (strong top-line acceleration)
Net income: $38.362M, +4.02% YoY (profit growth positive but slower than revenue)
EPS: $0.66, +15.79% YoY (solid per-share growth)
Takeaway: growth is clearly positive, with strong revenue expansion supporting the bull case even as net income growth is more moderate.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Trend: Ratings stayed bullish (Outperform) while price targets moved up over time.
2025-11-14 (Citizens JMP): Outperform, PT raised $23 → $26 on better-than-expected revenue/earnings and strong deployment.
2025-11-17 (Keefe Bruyette): Outperform, PT raised $22 → $28, citing low leverage and deployment capacity.
2025-12-23 (Keefe Bruyette): Outperform reiterated, PT $28, emphasizing normalization of the credit cycle and strong cash efficiency.
Wall Street pros: strong deployment/industry setup, low leverage, improving supply dynamics, strong operating efficiency.
Wall Street cons: despite bullish fundamentals, the current chart is not in a clean uptrend, implying timing risk even with a favorable long thesis.

4 Analyst Rating

Wall Street analysts forecast JCAP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JCAP is 27.25 USD with a low forecast of 26 USD and a high forecast of 29 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

0 Sell

Strong Buy

Current: 21.020

Low

Averages

27.25

High

Current: 21.020

Low

Averages

27.25

High

Keefe Bruyette

Outperform

maintain

$28

AI Analysis

2025-12-23

Reason

Keefe Bruyette

Price Target

$28

AI Analysis

2025-12-23

maintain

Outperform

Reason

Keefe Bruyette is positive on shares of Jefferson Capital heading into 2026. The firm reiterates an Outperform rating on the name with a $28 price target. Jefferson is well positioned to benefit from a continued normalization in the U.S. and international credit cycle, the analyst tells investors in a research note. Keefe is "constructive" on industry fundamentals as supply increases and believes the company is "industry-leading cash efficiency ratio should continue to drive strong returns."

Keefe Bruyette

Outperform

maintain

$22 -> $28

2025-11-17

Reason

Keefe Bruyette

Price Target

$22 -> $28

2025-11-17

maintain

Outperform

Reason

Keefe Bruyette raised the firm's price target on Jefferson Capital to $28 from $22 and keeps an Outperform rating on the shares. Jefferson Capital remains well-positioned to increase deployments given low leverage, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for JCAP

Unlock Now

JCAP Should I Buy

JCAP Should I Buy

Should You Buy Jefferson Capital Inc (JCAP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch